Details for New Drug Application (NDA): 019493
✉ Email this page to a colleague
NDA 019493 describes AMINOSYN II 3.5% M IN PLASTIC CONTAINER, which is a drug marketed by Abbott and is included in one NDA. Additional details are available on the AMINOSYN II 3.5% M IN PLASTIC CONTAINER profile page.
The generic ingredient in AMINOSYN II 3.5% M IN PLASTIC CONTAINER is amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.
The generic ingredient in AMINOSYN II 3.5% M IN PLASTIC CONTAINER is amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.
Summary for 019493
| Tradename: | AMINOSYN II 3.5% M IN PLASTIC CONTAINER |
| Applicant: | Abbott |
| Ingredient: | amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3.5%;32MG/100ML;128MG/100ML;222MG/100ML;49MG/100ML | ||||
| Approval Date: | Oct 16, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
